title: Low plasma levels of dehydroepiandrosterone (DHEA) and incidence of lipodystrophy.
authors.affiliation: Unité d'Immunologie Clinique and Université Pierre et Marie Curie, Hôpital Européen Georges Pompidou, France. christophe.piketty@egp.ap-hop-paris.fr
authors.forename: C
authors.initials: C
authors.lastname: Piketty
authors.forename: D
authors.initials: D
authors.lastname: Jayle
authors.forename: G
authors.initials: G
authors.lastname: Gonzalez-Canali
authors.forename: B
authors.initials: B
authors.lastname: Debuire
authors.forename: E E
authors.initials: EE
authors.lastname: Baulieu
authors.forename: M D
authors.initials: MD
authors.lastname: Kazatchkine
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001682:Biological Availability; D003687:Dehydroepiandrosterone / Q000008:administration & dosage* / Q000378:metabolism; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D019587:Dietary Supplements; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D006801:Humans; D015994:Incidence; D008060:Lipodystrophy / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D012307:Risk Factors; D012449:Safety; D016896:Treatment Outcome
chemical_list: D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate